GLAXOSMITHKLINE PHARMACEUTICALS LTD. - GlaxoSmithKline Pharmaceuticals Ltd reply to clarification sought by the exchange

	< Back
24 Dec 2014
The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd with respect to news article appearing in The Economic Times on December 24, 2014 titled "CCI gives approval for Novartis-GSK Pharma Deal"<BR> <BR>GlaxoSmithKline Pharmaceuticals Ltd replied stating "GSK Plc, an entity situated in UK indirectly holds shares of GlaxoSmithKline Pharmaceuticals Limited ("GSK India") and GSK India has not accepted any binding commitments in relation to the global deal. No filings and / or representations have been made by GSK India in the application for the approval filed by GSK Plc and Novartis. GSK India shall make all necessary disclosures as and when any obligation to do so arises under clause 36 of the listing agreement"
View all announcements for GLAXOSMITHKLINE PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us